275 related articles for article (PubMed ID: 26798348)
1. Two Cases of Sarcoma Arising in Giant Cell Tumor of Bone Treated with Denosumab.
Broehm CJ; Garbrecht EL; Wood J; Bocklage T
Case Rep Med; 2015; 2015():767198. PubMed ID: 26798348
[TBL] [Abstract][Full Text] [Related]
2. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
[TBL] [Abstract][Full Text] [Related]
3. Histopathological response to denosumab in giant cell tumours of bone - A review of 11 cases.
Kumar R; Mallya V; Mandal S; Tomar R; Khurana N; Maini L
J Cancer Res Ther; 2023; 19(3):768-772. PubMed ID: 37470608
[TBL] [Abstract][Full Text] [Related]
4. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
Agarwal MG; Gundavda MK; Gupta R; Reddy R
Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
[TBL] [Abstract][Full Text] [Related]
5. A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With Denosumab.
Aponte-Tinao LA; Piuzzi NS; Roitman P; Farfalli GL
Clin Orthop Relat Res; 2015 Sep; 473(9):3050-5. PubMed ID: 25758379
[TBL] [Abstract][Full Text] [Related]
6. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.
Roitman PD; Jauk F; Farfalli GL; Albergo JI; Aponte-Tinao LA
Hum Pathol; 2017 May; 63():89-97. PubMed ID: 28235628
[TBL] [Abstract][Full Text] [Related]
7. Development of high-grade osteosarcoma in a patient with recurrent giant cell tumor of the ischium while receiving treatment with denosumab.
Tsukamoto S; Righi A; Vanel D; Honoki K; Donati DM; Errani C
Jpn J Clin Oncol; 2017 Nov; 47(11):1090-1096. PubMed ID: 29048579
[TBL] [Abstract][Full Text] [Related]
8. Denosumab Therapy Obscures Histological Features of Giant Cell Tumor of Bone.
Gilani A; Kleinschmidt-DeMasters BK
J Neuropathol Exp Neurol; 2019 Dec; 78(12):1171-1173. PubMed ID: 31665371
[TBL] [Abstract][Full Text] [Related]
9. Malignant Sarcomatous Transformation of Benign Giant Cell Tumor of Bone after Treatment with Denosumab Therapy: A Literature Review of Reported Cases.
Alaqaili SI; Abduljabbar AM; Altaho AJ; Khan AA; Alherabi JA
Cureus; 2018 Dec; 10(12):e3792. PubMed ID: 30868006
[TBL] [Abstract][Full Text] [Related]
10. Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female - a case report and literature review.
Bardakhchyan S; Kager L; Danielyan S; Avagyan A; Karamyan N; Vardevanyan H; Mkhitaryan S; Papyan R; Zohrabyan D; Safaryan L; Sargsyan L; Harutyunyan L; Hakobyan L; Iskanyan S; Tamamyan G
Ital J Pediatr; 2017 Mar; 43(1):32. PubMed ID: 28356124
[TBL] [Abstract][Full Text] [Related]
11. Histopathological Features Of Denosumab Treated Giant Cell Tumours Of Bone "A Single Institutional Experience" At A Tertiary Care Center, Karachi.
Ali SM; Yaqoob N; Aftab Aslam K; Tauseef S; Ahmed SK; Jilani SAA; Jamal S
J Ayub Med Coll Abbottabad; 2022; 34(1):73-81. PubMed ID: 35466631
[TBL] [Abstract][Full Text] [Related]
12. Osteosarcoma of the Distal Femur Presenting as Giant Cell Tumor: A Case Report.
Ahmed S; Deshpande SV; Chhatbar K
Cureus; 2022 Dec; 14(12):e33173. PubMed ID: 36726918
[TBL] [Abstract][Full Text] [Related]
13. Benign giant cell tumor of bone with osteosarcomatous transformation ("dedifferentiated" primary malignant GCT): report of two cases.
Brien EW; Mirra JM; Kessler S; Suen M; Ho JK; Yang WT
Skeletal Radiol; 1997 Apr; 26(4):246-55. PubMed ID: 9151375
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases.
Deveci MA; Paydaş S; Gönlüşen G; Özkan C; Biçer ÖS; Tekin M
Acta Orthop Traumatol Turc; 2017 Jan; 51(1):1-6. PubMed ID: 27784623
[TBL] [Abstract][Full Text] [Related]
15. Anti-osteoclastic agent, denosumab, for a giant cell tumor of the bone with concurrent Paget's disease: A case report.
Tanaka T; Slavin J; McLachlan SA; Choong P
Oncol Lett; 2017 Apr; 13(4):2105-2108. PubMed ID: 28454368
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
Rekhi B; Verma V; Gulia A; Jambhekar NA; Desai S; Juvekar SL; Bajpai J; Puri A
Pathol Oncol Res; 2017 Jan; 23(1):157-164. PubMed ID: 27722984
[TBL] [Abstract][Full Text] [Related]
17. Morphologic evaluation of the effect of denosumab on giant cell tumors of bone and a new grading scheme.
Erdogan KE; DevecI MA; Paydas S; Gonlusen G
Pol J Pathol; 2016; 67(4):392-397. PubMed ID: 28547968
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous malignant transformation of conventional giant cell tumor.
Grote HJ; Braun M; Kalinski T; Pomjanski N; Back W; Bleyl U; Böcking A; Roessner A
Skeletal Radiol; 2004 Mar; 33(3):169-75. PubMed ID: 14749901
[TBL] [Abstract][Full Text] [Related]
19. Osteosarcoma arising from giant cell tumor of bone ten years after primary surgery: a case report and review of the literature.
Hashimoto K; Hatori M; Hosaka M; Watanabe M; Hasegawa T; Kokubun S
Tohoku J Exp Med; 2006 Feb; 208(2):157-62. PubMed ID: 16434839
[TBL] [Abstract][Full Text] [Related]
20. Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy.
Matcuk GR; Patel DB; Schein AJ; White EA; Menendez LR
Skeletal Radiol; 2015 Jul; 44(7):1027-31. PubMed ID: 25712768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
